Propofol infusion in critically ill patients is not associated with mitochondrial dysfunction or altered serum interleukin levels in the early sepsis response

Key Points

• To investigate the impact of propofol infusion on mitochondrial function and serum interleukin levels in critically ill patients during early sepsis response.
• Examined mitochondrial function metrics during propofol infusion.
• Monitored serum interleukin levels in critically ill patients with sepsis.
• Conducted comparisons across different immune response stages.
• Propofol infusion did not lead to significant mitochondrial dysfunction.
• Serum interleukin levels remained stable during the early sepsis response.
• There was no indication of altered immune cell function associated with propofol administration.